Decreased expression of the pro-apoptotic protein Par-4 in renal cell carcinoma

Oncogene

Volumn 18, Issue 5, 1999, Pages 1205-1208

  Cook, Jason ^a   Krishnan, Sumathi ^a   Ananth, Subbian ^c   Sells, Stephen F ^a   Shi, Yang ^c   Walther, McClellan M ^d   Linehan, W Marston ^d   Sukhatme, Vikas P ^c   Weinstein, Michael H ^a   Rangnekar, Vivek M ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Par 4; Renal cell carcinoma

Indexed keywords

LEUCINE ZIPPER PROTEIN;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DEFENSE MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MALIGNANT TRANSFORMATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, RENAL CELL; CARRIER PROTEINS; DOXORUBICIN; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY NEOPLASMS; KIDNEY TUBULES; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033521923     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202416     Document Type: Article

References (20)

1. Berra E, Municio MM, Sanz L, Frutos S, Diaz-Meco MT and Moscot JM. (1997) Mol. Cell. Biol., 17, 4346-4354.
2. Boghaert ER, Sells SF, Walid A-J, Collini P, Neil W, Weinstein M, Strange M and Rangnekar VM (1997). Cell Growth Differ., 8, 881-890.
3. Chen F, Kishida T, Yao M, Hustad T, Glavac D, Dean M, Gnarra JR, Orcutt ML, Duh FM and Glenn G. (1995). Hum. Mutat., 5, 66-75.
4. Crossey PA, Richards FM, Foster K, Green JS, Prowse A, Latif F, Lerner MI, Zbar B, Affara NA, Ferguson-Smith MA and Maher ER. (1994). Hum. Mol. Genet., 3, 1303-1308.
5. Diaz-Meco MT, Municio MM, Frutos S, Sanchez P, Lozano J, Sanz L and Moscat J. (1996). Cell, 86, 777-786.
6. Foster K, Prowse A, van der Berg A, Fleming S, Hulsbeek MMF, Crossey PA, Richards FM, Cairns P, Affara NA, Ferguson-Smith MA, Buys CHCM and Maher ER. (1994). Hum. Mol. Genet., 3, 2169-2173.
7. Gnarra JR, Tory, K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F and Duh FM. (1994). Nat. Genet., 7, 85-90.
8. Guo Q, Fu W, Xie J, Luo H, Sells SF, Geddes JW, Bondada V, Rangnekar VM and Mattson MP. (1998). Nat. Med., (in press).
9. Iliopoulos O, Kibel A, Gray S and Kaelin WGJ. (1995). Nat. Med., 1, 822-826.
10. Kerr JFR, Winterford CM and Harmon W. (1994). Cancer, 73, 2013.
11. Linehan WM, Lerman ML and Sbar B. (1995). JAMA, 273, 564-570.
12. Maher ER, Yates JR, Harries R, Benjamin C, Harris R, Moore AT and Ferguson-Smith MA. (1990). Quart. J. Med., 77, 1151-1163.
13. Pan H, Yin C and van Dyke T. (1997). Cancer Surveys, 29, 305-325.
14. Qiu G, Ahmed M, Sells S, Cookson M, Mohiuddin M, Weinstein M and Rangnekar VM. Oncogene, (in press).
15. Rangnekar VM. (1998). Apoptosis, 3, 61-66.
16. Sells SF, Wood DP, Barve SJ, Muthukumar S, Jacob RJ, Crist SC, Humphreys S and Rangnekar VM. (1994). Cell Growth Differ., 5, 457-466.
17. Sells SF, Han S-S, Muthukkumar S, Maddiwar N, Johnstone R, Boghaert E, Gillis D, Liu G, Nair P, Monnig S, Collini P, Mattson MP, Sukhatme VP, Zimmer SG, Wood Jr, DP, McRoberts JW, Shi Y and Rangnekar VM. (1997). Mol. Cell. Biol., 17, 3823-3832.
18. Walther MM, Anglard P, Gnarra J, Pozzatti R, Venzon D, de la Rosa A, MacDonald NJ, Steeg PS and Linehan WM. (1995). J. Urol., 154, 278-282.
19. Williams GT. (1991). Cell, 65, 1097-1098.
20. Wyllie AH. (1992). Cancer Metast. Rev., 11, 95-103.